Target- |
Mechanism- |
|
Originator Org.- |
Active Indication- |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
评价益髓生血颗粒治疗非输血依赖型地中海贫血的有效性及安全性的多中心随机双盲安慰剂平行对照Ⅱ期临床试验
[Translation] A multicenter randomized double-blind placebo-controlled phase II clinical trial evaluating the efficacy and safety of Yisui Shengxue Granules in the treatment of non-transfusion-dependent thalassemia
评价益髓生血颗粒治疗非输血依赖型地中海贫血(脾肾两虚、精血不足证)的有效性和安全性,同时对量-效关系进行探索,为Ⅲ期临床试验设计提供数据支持。
[Translation] To evaluate the efficacy and safety of Yisui Shengxue Granules in the treatment of non-transfusion-dependent thalassemia (syndrome of deficiency of spleen and kidney, deficiency of essence and blood), and to explore the dose-response relationship to provide data support for the design of phase III clinical trials.
100 Clinical Results associated with Beijing Plant Century Nutrition Co., Ltd.
0 Patents (Medical) associated with Beijing Plant Century Nutrition Co., Ltd.
100 Deals associated with Beijing Plant Century Nutrition Co., Ltd.
100 Translational Medicine associated with Beijing Plant Century Nutrition Co., Ltd.